A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy. https://t.co/oy64H1H2hb H/T @NCBI #radonc #PubMed https://t.co/yZwvc1qUiV
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
RT @JNeurooncol: New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neuros…
New support for the clinical practice of delaying radiation after surgery for 1p/19q codeleted #oligodendroglioma. #neurosurgery https://t.co/WPUtY9NYgA https://t.co/lZW4GqBWZD
#kuwcro: Collaboration is key to success!
Top story: A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy https://t.co/I4UaqQsX3B, see more https://t.co/rb2MBv6zsm
RT @WashURadOnc: See our Oligo collaboration with @Luriecancer @ColumbiaRadOnc @UMBaltimore in @JNeurooncol Takeaways: -Chemo alone does…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @TimothyKruserMD: Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone…
RT @WashURadOnc: See our Oligo collaboration with @Luriecancer @ColumbiaRadOnc @UMBaltimore in @JNeurooncol Takeaways: -Chemo alone does…
Fun working w/ top centers to examine outcomes in 1p/19q defined oligodendroglioma. Retrospective, but: 1) chemo alone doesn't look good. 2) practice of 59.4 Gy for gr 3 "AO" should be in our past. @zander_lin @TonyWangMD @BadiyanMD @JKMolitoris #radonc #
See our Oligo collaboration with @Luriecancer @ColumbiaRadOnc @UMBaltimore in @JNeurooncol Takeaways: -Chemo alone doesn't delay RT. -Dose >55Gy doesn't improve PFS, but 15% symptomatic radionecrosis. Keep dose 50-54 Gy! -Need RCT for obs vs chemo-RT